83.20
-0.18 (-0.22%)
-0.18 (-0.22%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.18 | -0.22% | 83.20 | 19:17:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 83.13 | 82.66 | 83.895 | 83.19 | 83.38 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 58,950 | 8,079,057 | $ 83.26 | $ 672,693,156 | 9,406,008 | 65.25 - 91.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:26:44 | 1 | $ 83.21 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 210.50B | 2.53B | 2.53B | $ 46.84B | $ 12.11B | 3.81 | 18.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.26 | 2.72% | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 85.31 | 85.31 | 81.5643 | 82.73 | 9,983,925 | -2.11 | -2.47% |
| 1 Month | 78.97 | 85.60 | 78.2401 | 82.15 | 8,268,180 | 4.23 | 5.36% |
| 3 Months | 79.08 | 85.60 | 73.94 | 80.63 | 9,061,998 | 4.12 | 5.21% |
| 6 Months | 79.87 | 87.80 | 73.94 | 81.45 | 8,493,305 | 3.33 | 4.17% |
| 1 Year | 90.72 | 91.01 | 65.25 | 79.93 | 10,326,058 | -7.52 | -8.29% |
| 3 Years | 61.48 | 92.64 | 52.83 | 75.61 | 10,035,608 | 21.72 | 35.33% |
| 5 Years | 51.60 | 92.64 | 47.97 | 69.68 | 9,613,854 | 31.60 | 61.24% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
